Brookdale Senior Living (BKD) RBC Capital Markets Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
RBC Capital Markets Global Healthcare Conference 2026 summary
20 May, 2026Strategic direction and organizational changes
Entering a new growth-focused chapter, moving past COVID and cash flow challenges, with positive cash flow projected to increase this year.
Significant organizational restructuring, including new leadership and operational realignment, now largely stabilized.
Disposed of over 100 assets in the past year, with only a few remaining, marking a shift to a steady-state portfolio.
Portfolio now optimized for market presence and operational efficiency, with targeted acquisitions considered for further growth.
Revenue management and pricing strategy
Implemented high single-digit in-place rent increases, with low double-digit increases in highly occupied communities and mid-single-digit in lower occupancy ones.
Two-speed approach: premium pricing in high-occupancy markets, discounting to drive occupancy in lower-occupied communities.
RevPAR guidance for the year is 8%-9%, with RevPOR expected to step down in Q2 but hold steady in Q3 and Q4 due to accretion impacts.
Pricing power remains strong in markets with 95%+ occupancy, enabling rate increases without significant move-outs.
Operational performance and financial outlook
Sequential RevPOR increased 6.3% from Q4 to Q1, with consolidated RevPOR up 4.5% due to disposition accretion.
EBITDA per unit rises sharply with occupancy, from $4,800 in low-occupancy to nearly $20,000 in high-occupancy bands.
Second half EBITDA ramp driven by occupancy gains, RevPOR/ExPOR spread, and G&A savings from managed contract exits.
Lease portfolio now cash flow positive, with margins above 33% and a fixed 3% escalator, contributing positively to EBITDA.
Latest events from Brookdale Senior Living
- Occupancy and EBITDA are set to rise as strategic changes and strong demand drive growth.BKD
Bank of America Global Healthcare Conference 202613 May 2026 - Q1 2026 saw strong RevPAR and occupancy gains, improved profitability, and reaffirmed guidance.BKD
Q1 202613 May 2026 - Director elections, executive pay, and auditor ratification headline the 2026 annual meeting.BKD
Proxy filing30 Apr 2026 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.BKD
Proxy filing30 Apr 2026 - Record 2025 EBITDA and occupancy growth set the stage for robust 2026 performance.BKD
Q4 202510 Apr 2026 - Operational focus, targeted CapEx, and market-driven M&A support growth amid strong demand.BKD
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Q2 saw 20% Adjusted EBITDA growth, higher occupancy, but a wider net loss on higher costs.BKD
Q2 20241 Feb 2026 - 2026 targets $502–$516M Adjusted EBITDA and 8–9% RevPAR growth, led by operational transformation.BKD
Investor Day 202630 Jan 2026 - Q3 2024 delivered 15% EBITDA growth, higher occupancy, and $610M in acquisitions pending.BKD
Q3 202415 Jan 2026